ArticleMedical oncology (Northwood, London, England)2014

Bevacizumab improves the antitumor efficacy of adoptive cytokine-induced killer cells therapy in non-small cell lung cancer models.

Leilei Tao et al.PubMed ↗Publisher ↗

No numbers read from the abstract.